Lovir 800 mg 35 tablets
Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Composition:
Each oral dispersible tablet contains Acyclovir 800 mg (active ingredient).
Product description
Antiviral nucleoside analogue. Inhibits viral DNA polymerase, preventing replication of herpes viruses.
Oral dispersible tablet formulation allows easier administration, especially for patients with swallowing difficulties.
Indications for use
Treatment of herpes zoster (shingles), varicella (chickenpox), and herpes simplex virus (HSV) infections (e.g., genital herpes), per clinical judgment and local labeling.
Method of administration and dosage
Oral; take with water.
Typical adult regimen for herpes zoster: acyclovir 800 mg five times daily for ~7 days.
Dosing may differ for HSV/varicella and requires adjustment in renal impairment; follow doctor’s advice.
Contraindications
Hypersensitivity to acyclovir or valacyclovir; consider risks in severe renal impairment.
Precautions
Ensure adequate hydration; reduce dose in renal impairment and older adults.
Monitor for neurotoxicity in high doses/renal dysfunction.
Use caution with concomitant nephrotoxic drugs.
Adverse reactions (side effects)
Common: headache, dizziness, diarrhea, abdominal pain, indigestion, nausea.
Less common: rash, pruritus, fatigue.
Rare/serious: renal dysfunction, neurotoxicity (confusion, tremor), hypersensitivity reactions.
Pregnancy and lactation
Use only if potential benefit outweighs risk; acyclovir is excreted in breast milk-exercise caution during lactation.
Storage conditions
Store below 25-30°C, protected from moisture and light.
Keep out of reach of children.
Packaging
Carton containing 35 oral dispersible tablets (800 mg), in blister packs, with inner leaflet.